Company news
Medicure Inc. news in 2019
Medicure Inc.'s news releases, calls and decks from 2019, newest first.
Early Warning News Release - Dr. Albert D. Friesen Holdings in Medicure Inc.
December 31, 2019
Medicure Announces Preliminary Results of Substantial Issuer Bid
December 20, 2019
Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study
December 17, 2019
Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)
December 12, 2019
Medicure Announces Settlement of Holdback Dispute from Apicore Sale
December 5, 2019
Medicure Files Patent Infringement Action
December 5, 2019
Medicure Reports Financial Results for Quarter Ended September 30, 2019
November 26, 2019
Medicure Q3 2019 Results and Conference Call Dates
November 19, 2019
Medicure Announces Commencement of Substantial Issuer Bid
November 13, 2019
Medicure Announces Intention to Commence Substantial Issuer Bid
November 4, 2019
Medicure Announces SMILE(TM)-HF Study Demonstrates Use of ReDS(TM) Results in 58% Reduction in Hospital Readmission Rate
October 15, 2019
Medicure Announces Preferred Pricing Agreement for Zypitamag(TM) with the AIDS Drug Assistance Program ("ADAP") Crisis Task Force
October 3, 2019
Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag(TM)
September 30, 2019
Medicure Announces Launch of New and Improved ReDS(TM) PRO
September 17, 2019
Medicure Reports Financial Results for Quarter Ended June 30, 2019
August 8, 2019
Medicure Q2 2019 Results and Conference Call Dates
August 2, 2019
Medicure Announces Results of 2019 Annual Meeting of Shareholders
June 26, 2019
Medicure Announces Appoinment of Dr. Neil Owens as President and Chief Operating Officer
June 10, 2019
Medicure Announces Renewal of its Normal Course Issuer Bid
May 30, 2019
Medicure Reports Financial Results for Quarter Ended March 31, 2019
May 27, 2019
Medicure Q1 2019 Results and Conference Call Dates
May 22, 2019
Medicure Appoints Ms. Manon Harvey to its Board of Directors
May 15, 2019
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2018
April 29, 2019
Medicure to Announce Fiscal Year End 2018 Financial Results on April 29, 2019
April 24, 2019
Medicure Provides Update on Release of Holdback Funds from Apicore Sale
February 13, 2019
Medicure Announces Agreement to Market ReDS(TM) Device for Congestive Heart Failure Patients in the United States
January 28, 2019